PF-03550096
PF-03550096 is a drug that acts as a potent agonist for the CB 2 cannabinoid receptor, with good selectivity over CB 1 having K i values of 7nM at CB 2 and 1500nM at CB 1 .
≈ 1 min read
PF-03550096. encyclopegia.org, snapshot enwiki-001268766513. /a/pf-03550096
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
PF-03550096 is a drug that acts as a potent agonist for the CB 2 cannabinoid receptor, with good selectivity over CB 1 having K i values of 7nM at CB 2 and 1500nM at CB 1 . It was originally developed by Pfizer in 2008 as a medication for irritable bowel syndrome, but has only progressed to animal studies.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1268766513 under CC BY-SA 4.0; modifications have been made.